ArticleThe Journal of biological chemistry2026
ZBTB38 requires an extended N-terminal zinc finger network to read mCpG- and discriminate TpG-containing DNA sequences.
Article in The Journal of biological chemistry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
- Update of
Authors and funding
7 authors.
Funding
Abstract
Methylation of cytosine bases in the CpG context (mCpG) is an essential regulatory mechanism cells use to spatially and temporally orchestrate access to genomic regions and mediate transcription. In many diseases, DNA methylation patterns become inappropriately distributed, leading to aberrant transcriptional outcomes. Methyl-CpG binding proteins (MBPs) are key epigenetic mediators that selectively recognize mCpG sites, translating these signals into discrete transcriptional responses. ZBTB38 is a zinc finger (ZF) MBP that uniquely harbors two sets of five ZF clusters; each capable of selectively distinguishing mCpG sites. While the cognate DNA sequence and molecular basis for selective mCpG recognition have been defined for the ZBTB38 C-terminal (C-term) ZF domain, the molecular basis for differentiating DNA targets by the N-terminal (N-term) ZF domain remained uncharacterized. Here we report the mCpG-containing consensus sequence for the ZBTB38 N-term ZFs and demonstrate that, unlike the other two ZBTB MBP family members ZBTB33 (Kaiso) and ZBTB4, the conserved three N-term ZF domain discriminates against binding to TpG-containing DNA, and that at least one additional N-term ZF is required to stabilize DNA engagement. In addition, we demonstrate that each ZBTB38 ZF domain exhibits preferential target recognition for its respective cognate methylated DNA consensus motif. These findings expand understanding of how ZBTB38 mediates epigenetic-based transcriptional processes in normal and disease-state cells by providing new insight into the molecular basis by which the ZBTB38 N-term ZF domain differentiates DNA targets and offering further insight into the interplay between the N- and C-term ZF domains in directing cellular activities.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.